Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE): Outcomes at 12 months
Johnson M, Spies J, Scott K, Kato B, Mu X, Rectenwald J, White R, Lewandowski R, Khaja M, Zuckerman D, Casciani T, Gillespie D. Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE): Outcomes at 12 months. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2023, 11: 573-585.e6. PMID: 36872169, DOI: 10.1016/j.jvsv.2022.11.002.Peer-Reviewed Original ResearchConceptsVena cava filtersEnd pointCava filtersPrimary effectiveness end pointPrimary safety end pointInferior vena cava filterEffectiveness end pointSafety end pointVenous thromboembolic eventsProphylactic placementAnticoagulation therapyThromboembolic eventsVenous thromboembolismThrombotic occlusionNonrandomized studyPrimary safetyTomography scanLower incidenceSignificant PESite investigatorsPatientsCore laboratoryStrut perforationMonthsDVTPredicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE): Outcomes at 12 months
Johnson M, Spies J, Scott K, Kato B, Mu X, Rectenwald J, White R, Lewandowski R, Khaja M, Zuckerman D, Casciani T, Gillespie D. Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE): Outcomes at 12 months. Journal Of Vascular And Interventional Radiology 2023, 34: 517-528.e6. PMID: 36841633, DOI: 10.1016/j.jvir.2022.12.009.Peer-Reviewed Original ResearchConceptsVena cava filtersEnd pointCava filtersPrimary effectiveness end pointPrimary safety end pointInferior vena cava filterEffectiveness end pointSafety end pointVenous thromboembolic eventsProphylactic placementAnticoagulation therapyThromboembolic eventsVenous thromboembolismThrombotic occlusionNonrandomized studyPrimary safetyTomography scanLower incidenceSignificant PESite investigatorsPatientsCore laboratoryStrut perforationMonthsDVT